International Stem Cell Corporation , a California-based biotechnology company focused on therapeutic and biomedical products, today announced financial results for the three and twelve months ended December 31, 2012.
http://www.biospace.com/news_story.aspx?StoryID=291721&full=1
http://www.biospace.com/news_story.aspx?StoryID=291721&full=1
No comments:
Post a Comment